Kevin M. Coen and Stephanie H. Saran Rudolph of Morris, Nichols, Arsht & Tunnell have stepped in to represent the top officials of biotech company Bioventus in a pending shareholder derivative lawsuit. The complaint, filed Oct. 4 in Delaware District Court by Bronstein Gewirtz & Grossman, Farnan LLP and the Brown Law Firm on behalf of Mary Grogan, accuses the defendants of concealing financial issues allegedly caused by overexpansion, regulatory changes to Medicare and a failure to account for rebates to insurers when calculating revenue projections, triggering a securities class action against the company. The case, assigned to U.S. District Judge Richard G. Andrews, is 1:23-cv-01099, Grogan v. Reali et al.

This suit was surfaced by Law.com Radar, a source for high-speed legal news and litigation updates personalized to your practice. Law.com Radar publishes daily updates on just-filed federal cases like this one. Click here to get started and be first to know about new suits in your region, practice area or client sector.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]